JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLCEun Ji Lee, Sun Min Lim|Clinical Cancer Research|2026Cited by 1